These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3959902)

  • 1. Cancer cachexia and the rate of whole body lipolysis in man.
    Jeevanandam M; Horowitz GD; Lowry SF; Brennan MF
    Metabolism; 1986 Apr; 35(4):304-10. PubMed ID: 3959902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole body lipid and energy metabolism in the cancer patient.
    Legaspi A; Jeevanandam M; Starnes HF; Brennan MF
    Metabolism; 1987 Oct; 36(10):958-63. PubMed ID: 3657515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycerol dynamics in weight-losing cancer patients.
    Edén E; Edström S; Bennegárd K; Lindmark L; Lundholm K
    Surgery; 1985 Feb; 97(2):176-84. PubMed ID: 4038560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer cachexia and protein metabolism.
    Jeevanandam M; Horowitz GD; Lowry SF; Brennan MF
    Lancet; 1984 Jun; 1(8392):1423-6. PubMed ID: 6145877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons.
    Lillioja S; Foley J; Bogardus C; Mott D; Howard BV
    Metabolism; 1986 Jun; 35(6):505-14. PubMed ID: 3713512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body lipolysis and triglyceride-fatty acid cycling in cachectic patients with esophageal cancer.
    Klein S; Wolfe RR
    J Clin Invest; 1990 Nov; 86(5):1403-8. PubMed ID: 2243120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of increased lipolysis in cancer cachexia.
    Agustsson T; Rydén M; Hoffstedt J; van Harmelen V; Dicker A; Laurencikiene J; Isaksson B; Permert J; Arner P
    Cancer Res; 2007 Jun; 67(11):5531-7. PubMed ID: 17545636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased catabolic activity in adipose tissue of patients with chronic heart failure.
    Szabó T; Postrach E; Mähler A; Kung T; Turhan G; von Haehling S; Anker SD; Boschmann M; Doehner W
    Eur J Heart Fail; 2013 Oct; 15(10):1131-7. PubMed ID: 23696611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance.
    Arner P; Langin D
    Trends Endocrinol Metab; 2014 May; 25(5):255-62. PubMed ID: 24731595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.
    Drott C; Persson H; Lundholm K
    Clin Physiol; 1989 Oct; 9(5):427-39. PubMed ID: 2582730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
    Puhakainen I; Koivisto VA; Yki-Järvinen H
    J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects.
    Zuijdgeest-van Leeuwen SD; van den Berg JW; Wattimena JL; van der Gaast A; Swart GR; Wilson JH; Dagnelie PC
    Metabolism; 2000 Jul; 49(7):931-6. PubMed ID: 10910006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free fatty acid turnover and lipolysis in septic mechanically ventilated cancer-bearing humans.
    Levinson MR; Groeger JS; Jeevanandam M; Brennan MF
    Metabolism; 1988 Jul; 37(7):618-25. PubMed ID: 3386532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome.
    Henriques FS; Sertié RAL; Franco FO; Knobl P; Neves RX; Andreotti S; Lima FB; Guilherme A; Seelaender M; Batista ML
    FASEB J; 2017 May; 31(5):1976-1986. PubMed ID: 28138038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.
    Groundwater P; Beck SA; Barton C; Adamson C; Ferrier IN; Tisdale MJ
    Br J Cancer; 1990 Nov; 62(5):816-21. PubMed ID: 2245173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of lipid-depleting factor in a colon-26-inoculated cancer cachexia model.
    Inadera H; Nagai S; Dong HY; Matsushima K
    Int J Cancer; 2002 Sep; 101(1):37-45. PubMed ID: 12209586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic fermentation from lactulose inhibits lipolysis in overweight subjects.
    Ferchaud-Roucher V; Pouteau E; Piloquet H; Zaïr Y; Krempf M
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E716-20. PubMed ID: 16150956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation.
    Zuijdgeest-Van Leeuwen SD; Dagnelie PC; Wattimena JL; Van den Berg JW; Van der Gaast A; Swart GR; Wilson JH
    Clin Nutr; 2000 Dec; 19(6):417-23. PubMed ID: 11104593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic response of whole body and peripheral tissues to enteral nutrition in weight-losing cancer and noncancer patients.
    Bennegård K; Edén E; Ekman L; Scherstén T; Lundholm K
    Gastroenterology; 1983 Jul; 85(1):92-9. PubMed ID: 6406291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipolysis--not inflammation, cell death, or lipogenesis--is involved in adipose tissue loss in cancer cachexia.
    Rydén M; Agustsson T; Laurencikiene J; Britton T; Sjölin E; Isaksson B; Permert J; Arner P
    Cancer; 2008 Oct; 113(7):1695-704. PubMed ID: 18704987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.